74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Enfusion Inc (Class A)
Closed
11.49 1.23
Overview
Share price change
24h
Min
11.47
Max
11.54
Income | 630K 2.5M |
|---|---|
Sales | 1.7M 51M |
P/E Sector Avg | 276.75 111.403 |
EPS | 0.05 |
Profit margin | 4.8 |
Employees | 1,102 |
EBITDA | 245K 5.8M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | -1.48 downside |
Next Earnings | 11 Mar 2025 |
|---|
Market Cap | 1B |
|---|---|
Previous open | 10.26 |
Previous close | 11.49 |
Enfusion Inc (Class A) Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Enfusion Inc (Class A) Forecast
Price Target
By TipRanks
-1.48% downside
12 Months Forecast
Average 11.33 USD -1.48%
High 11.5 USD
Low 11.25 USD
Based on 4 Wall Street analysts offering 12 month price targets forEnfusion Inc (Class A) - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Enfusion Inc (Class A)
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.
